CardioVascular Virtual Topics 2022

Residual cardiovascular risk. What is the role of icosapent ethyl?

Fecha de emisión: Martes, 10 mayo 2022 18:00h

Participants

Prof. José Luis Zamorano
Prof. José Luis ZamoranoHospital Universitario Ramón y Cajal, Madrid (Spain)
Residual cardiovascular risk. We can do more!
Prof. Alberto Zambon
Prof. Alberto Zambon Università di Padova (Italy)
Residual CV risk: what is this? Role of lipids and inflammation and how to identify the patient
Prof. John Chapman
Prof. John Chapman Hôpital Pitie-Salpêtrière, Paris (France)
Icosapent ethyl MoA: what do we know?
Prof. Xavier Garcia-Moll
Prof. Xavier Garcia-Moll Hospital de la Santa Creu i Sant Pau, Barcelona (Spain)
Icosapent ethyl: evidence and guidelines recommendations

Un proyecto de

SEC

Con la colaboración de

AMARIN

© 2022 Sociedad Española de Cardiología. Todos los derechos reservados.Ciclos Online SEC

Please publish modules in offcanvas position.